Covered recipient · General Payments record
KAREN A RUBEL
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,685.35
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $324.57 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ALK-Abello, Inc | $90.75 | 5 |
| Merck Sharp & Dohme Corporation | $75.12 | 3 |
| Kaleo, Inc. | $71.50 | 3 |
| PFIZER INC. | $36.44 | 2 |
| Cranial Technologies, Inc | $18.10 | 1 |
| Neurelis, Inc. | $17.96 | 1 |
| GlaxoSmithKline, LLC. | $14.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ALK-Abello, Inc | $18.79 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099894789 | CMS |
| ALK-Abello, Inc | $17.54 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099894785 | CMS |
| ALK-Abello, Inc | $16.44 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099894783 | CMS |
| ALK-Abello, Inc | $18.79 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099894787 | CMS |
| ALK-Abello, Inc | $19.19 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099894791 | CMS |
| Cranial Technologies, Inc | $18.10 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082222622 | CMS |
| GlaxoSmithKline, LLC. | $14.70 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115943926 | CMS |
| kaleo, Inc. | $26.34 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126626663 | CMS |
| kaleo, Inc. | $24.64 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126626665 | CMS |
| kaleo, Inc. | $20.52 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126626667 | CMS |
| Merck Sharp & Dohme LLC | $25.59 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141807999 | CMS |
| Merck Sharp & Dohme LLC | $24.90 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141969577 | CMS |
| Merck Sharp & Dohme LLC | $24.63 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141963959 | CMS |
| Neurelis, Inc. | $17.96 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145652612 | CMS |
| PFIZER INC. | $17.38 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131167978 | CMS |
| PFIZER INC. | $19.06 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131070160 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.